Identification of protein-protein interactions of human HtrA1

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 4, 2011, Pages 1493-1499

  Campioni, Mara ^a   Severino, Anna ^b   Manente, Lucrezia ^a   De Luca, Antonio ^a   La Porta, Raffaele ^a   Vitiello, Antonio ^a   Fiore, Paola ^a   Toldo, Stefano ^c   Spugnini, Enrico P ^d   Paggi, Marco G ^d   Baldi, Alfonso ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer; HtrA1; Protein protein interaction; Two hybrid

Indexed keywords

COLLAGEN; COMPLEMENTARY DNA; HEAT SHOCK PROTEIN; HTRA1 PROTEIN; HTRA1 S328A PROTEIN; MUTANT PROTEIN; TUBERIN; TUBULIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; HTRA1 PROTEIN, HUMAN; PRIMER DNA; SERINE PROTEINASE;

ARTICLE; CELL GROWTH; DNA LIBRARY; ENZYME ACTIVITY; ENZYME INACTIVATION; EXTRACELLULAR MATRIX; FETUS; HUMAN; HUMAN CELL; MELANOMA CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TWO HYBRID SYSTEM; YEAST; CELL LINE; GENETICS; METABOLISM; PROTEIN BINDING;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; SERINE ENDOPEPTIDASES;

EID: 80053581615     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Lipinska B, Sharma S, Georgopoulos C: Sequence analysis and regulation of the htrA gene of Escherichia coli: a sigma 32-independent mechanism of heat-inducible transcription. Nucleic Acids Res 16(21):10053-10067 (1988) (Pubitemid 18264971)
2. Strauch KL, Beckwith J: An Escherichia coli mutation preventing degradation of abnormal periplasmic proteins. Proc Natl Acad Sci U S A 85(5):1576-1580 (1988)
3. Zumbrunn J and Trueb B: Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett. 398:187-192 (1996) (Pubitemid 26414307)
4. Hu, SI, Carozza M, Klein M, Nantermet P, Luk D and Crowl RM: Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. J Biol Chem 273:34406-34412 (1998) (Pubitemid 29008919)
5. Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV, Zervos AS: Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem 275(4):2581-2588 (2000) (Pubitemid 30082024)
6. Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D, Southan C, Barton A, Fantom KG, West A, Savopoulos J, Hassan NJ, Clinkenbeard H, Hanning C, Amegadzie B, Davis JB, Dingwall C, Livi GP, Creasy CL. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 267(18):5699-5710 (2000)
7. Nie GY, Hampton A, Li Y, Findlay JK, Salamonsen LA. Identification and cloning of two isoforms of human high-temperature requirement factor A3(HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. Biochem J 371 (Pt 1):39-48 (2003) (Pubitemid 36458077)
8. De Luca A, De Falco M, Fedele V, Cobellis L, Mastrogiacomo A, Laforgia V, Tuduce IL, Campioni M, Giraldi D, Paggi MG, Baldi A: The serine protease HtrA1 is upregulated in the human placenta during pregnancy. J Histochem Cytochem 52(7):885-892 (2004) (Pubitemid 38857153)
9. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M: HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131(5):1041-1053 (2004) (Pubitemid 38380458)
10. De Luca A, De Falco M, Severino A, Campioni M, Santini D, Baldi F, Paggi MG, Baldi A: Distribution of the serine protease HtrA1 in normal human tissues. J Histochem Cytochem 51(10):1279-1284 (2003) (Pubitemid 37187579)
11. Lorenzi T, Marzioni D, Giannubilo S, Quaranta A, Crescimanno C, De Luca A, Baldi A, Todros T, Tranquilli AL, Castellucci M: Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. Placenta 30(1):35-40 (2009)
12. Grau S, Richards PJ, Kerr B, Hughes C, Caterson B, Williams AS, Junker U, Jones SA, Clausen T, Ehrmann M: The role of human HtrA1 in arthritic disease. J Biol Chem 281(10):6124 (2006)
13. Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F, Catricalà C, Amantea A, Noonan DM, Albini A, Natali PG, Lombardi D, Paggi MG: The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Oncogene 21(43):6684-8 (2002) (Pubitemid 35177048)
14. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6(1):17-32 (2004) (Pubitemid 38903159)
15. Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH, Shridhar V: A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 23(8):1636-1644 (2004) (Pubitemid 38406528)
16. Narkiewicz J, Klasa-Mazurkiewicz D, Zurawa-Janicka D, Skorko-Glonek J, Emerich J, Lipinska B: Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer. Clin Biochem 41(7-8):561-569 (2008)
17. Bowden MA, Di Nezza-Cossens LA, Jobling T, Salamonsen LA, Nie G: Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer. Gynecol Oncol 103(1):253-260 (2006) (Pubitemid 44374697)
18. Esposito V, Campioni M, De Luca A, Spugnini EP, Baldi F, Cassandro R, Mancini A, Vincenzi B, Groeger A, Caputi M, Baldi A: Analysis of HtrA1 serine protease expression in human lung cancer. Anticancer Res 26(5A):3455-3459 (2006) (Pubitemid 44701522)
19. Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Marino M, Di Crescenzo VG, Visca P, Menegozzo S, Spugnini EP, Citro G, Ceribelli A, Mirri A, Chien J, Shridhar V, Ehrmann M, Santini M, Facciolo F: The serine protease HtrA1 is a novel prognostic factor for human mesothelioma. Pharmacogenomics 9(8):1069-1077 (2008)
20. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V: Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J Clin Invest 116(7):1994-2004 (2006) (Pubitemid 44033323)
21. Chien J, Campioni M, Shridhar V, Baldi A: HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets 9(4):451-468 (2009)
22. Murwantoko, Yano M, Ueta Y, Murasaki A, Kanda H, Oka C, Kawaichi M: Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. Biochem J 381(Pt 3):895-904 (2004) (Pubitemid 39120501)
23. Tsuchiya A, Yano M, Tocharus J, Kojima H, Fukumoto M, Kawaichi M, Oka C: Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis. Bone 37(3):323-336 (2005) (Pubitemid 41160491)
24. Chamberland A, Wang E, Jones AR, Collins-Racie LA, La Vallie ER, Huang Y, Liu L, Morris EA, Flannery CR, Yang Z. Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo. J Biol Chem 284(40):27352-27359 (2009)
25. Grau S, Baldi A, Bussani R, Tian X, Stefanescu R, Przybylski M, Richards P, Jones SA, Shridhar V, Clausen T, Ehrmann M: Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci USA 102(17):6021-6026 (2005) (Pubitemid 40594248)
26. A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J: HtrA1 promoter polymorphism in wet agerelated macular degeneration. Science 314(5801):989-992 (2006) (Pubitemid 44749943)
27. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314(5801):992-993 (2006) (Pubitemid 44749944)
28. Weger M, Renner W, Steinbrugger I, Köfer K, Wedrich A, Groselj-Strele A, El-Shabrawi Y, Schmut O, Haas A: Association of the HTRA1-625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis 13:1274-1279 (2007) (Pubitemid 47128954)
29. Chen W, Xu W, Tao Q, Liu J, Li X, Gan X, Hu H, Lu Y. Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration. Exp Eye Res 89(3):292-300 (2009)
30. Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, Zupi G: Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. Clin Cancer Res 5(9):2588-2595 (1999) (Pubitemid 29437346)
31. Hadfield KD, Rock CF, Inkson CA, Dallas SL, Sudre L, Wallis GA, Boot-Handford RP, Canfield AE: HtrA1 inhibits mineral deposition by osteoblasts: requirement for the protease and PDZ domains. J Biol Chem 283(9):5928-5938 (2008)
32. Clausen T, Southan C, Ehrmann M: The HtrA family of proteases: implications for protein composition and cell fate. Mol Cell 10(3):443-455 (2002) (Pubitemid 35284166)
33. Canfield AE, Hadfield KD, Rock CF, Wylie EC, Wilkinson FL: HtrA1:a novel regulator of physiological and pathological matrix mineralization? Biochem Soc Trans 35(4):669-671 (2007) (Pubitemid 47310337)
34. An E, Sen S, Park SK, Gordish-Dressman H, Hathout Y: Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Invest Ophthalmol Vis Sci. 51(7):3379-86 (2010)
35. Brocker CN, Vasiliou V, Nebert DW: Evolutionary divergence and functions of the ADAM and ADAMTS gene families. Hum Genomics 4(1):43-55 (2009)
36. Liu CJ, Kong W, Ilalov K, Yu S, Xu K, Prazak L, Fajardo M, Sehgal B, Di Cesare PE. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J 20(7):988-990 (2006)
37. Luan Y, Kong L, Howell DR, Ilalov K, Fajardo M, Bai XH, Di Cesare PE, Goldring MB, Abramson SB, Liu CJ. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin. Osteoarthritis Cartilage 16(11):1413-1420 (2008)
38. Chessler SD and Byers PH: Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern. J Biol Chem 267 (11):7751-7757 (1992)
39. R, Franke WW: Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family. Differentiation 61(5):293-304 (1997) (Pubitemid 27440398)
40. Zhou J, Liyanage U, Medina M, Ho C, Simmons AD, Lovett M, Kosik KS. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8(6):1489-1494 (1997) (Pubitemid 27242561)
41. Ho C, Zhou J, Medina M, Goto T, Jacobson M, Bhide PG, Kosik KS. delta-catenin is a nervous system-specific adherens junction protein which undergoes dynamic relocalization during development. J Comp Neurol 420(2):261-276 (2000) (Pubitemid 30185982)
42. Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S, Chen YH: Increased expression of deltacatenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer. Hum Pathol 36(10):1037-1048 (2005) (Pubitemid 41443254)
43. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HFJr, Hampton GM: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61(16), 5974-5978 (2006)
44. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM: Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8(5):393-406 (2005) (Pubitemid 41579834)
45. Chien J, Ota T, Aletti G, Shridhar R, Boccellino M, Quagliuolo L, Baldi A, Shridhar V. Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol Cell Biol 29(15):4177-4187 (2009)
46. Segade F. Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. Gene 464 (1-2) 17-31 (2010)
47. Argraves WS, Dickerson K, Burgess WH, Ruoslahti E: Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain. Cell 58(4):623-629 (1989) (Pubitemid 19210956)
48. Cheadle JP, Reeve MP and Kwiakowski DJ: Molecular genetic advances in tuberous sclerosis. Hum Genet 107:97-114 (2000)
49. Green AJ, Smith M, and Yates JR: Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6:193-196 (1994) (Pubitemid 24188602)
50. Green AJ, Johnson PH and Yates JR: The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum. Mol Genet 3:1833-1834 (1994) (Pubitemid 24310480)
51. Campioni M, Severino A, Manente L, Tuduce IL, Toldo S, Caraglia M, Crispi S, Ehrmann M, De Falco M, De Luca A, He X, Maguire J, Shridhar V, Baldi A. The serine protease HtrA1 specifically interacts and degrades the Tuberous Sclerosis Complex 2 protein (TSC2). Mol Cancer Res 8(9):1248-1260 (2010)